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Abstract
Background: Studies suggest that free-ranging bottlenose dolphins exhibit a suppressed immune system because
of exposure to contaminants or microorganisms. However, due to a lack of commercially available antibodies
specific to marine mammal immune cell surface markers, the research has been indecisive. The purpose of this
study was to identify cross-reactive terrestrial-specific antibodies in order to assess the changes in the immune
cell populations of dolphins under human care and free-ranging dolphins. The blood and PBMC fraction of blood
samples from human care and free-ranging dolphins were characterized by H&E staining of cytospin slides and flow
cytometry using a panel of terrestrial-specific antibodies.
Results: In this study, we show that out of 65 terrestrial-specific antibodies tested, 11 were cross-reactive and identified
dolphin immune cell populations within their peripheral blood. Using these antibodies, we found significant differences
in the absolute number of cells expressing specific markers within their lymphocyte and monocyte fractions. Interestingly,
the peripheral blood mononuclear cell profile of free-ranging dolphins retained an additional population of cells
that divided them into two groups showing a low (<27%) or high (>56%) percentage of smaller cells resembling
granulocytes.
Conclusions: We found that the cross-reactive antibodies not only identified specific changes in the immune
cells of free-ranging dolphins, but also opened the possibility to investigate the causal relationship between
immunosuppression and mortality seen in free-ranging dolphins.
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Background
In recent years there has been a drastic increase in the
number of cetacean strandings and mortalities along the
coast of the United States, which the National Marine
Fisheries Service (NMFS) has termed unusual mortality
events (UMEs). UMEs have been occurring yearly amongst
a variety of marine species in different areas of the U.S.
However, one of the largest UMEs which began in July
2013 has affected hundreds of bottlenose dolphins along
the Atlantic coast of the U.S. [1]. Although it is often very
difficult to determine the cause of an UME, NMFS
attributes many to biotoxins, ecological factors, infectious
diseases, such as morbillivirus [2], or human interactions
[3]. Interestingly, studies have shown that high trophic level
predators, such as dolphins, have very high concentrations
of brevetoxin [4] and chemical pollutants [5] in their tissues
as a result of consuming lower trophic level fish that also
have high concentrations of these contaminants.
Animal and human studies have demonstrated the
importance of the immune system for combating infec-
tious diseases and cancer. Indeed, number of reports
suggest a correlation between environmental contami-
nants, immunosuppression, and diseases susceptibility
in marine mammals. For example, several studies have
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found changes in immunological parameters, such as
absolute number of eosinophils and lymphocytes [6]
and lymphocyte proliferation in dolphins exposed to
certain contaminants [7–9] that may adversely lead to
cell anergy or autoimmune diseases [7, 8]. Other studies
showed an inverse correlation between contaminant levels
and immune cells and their function in marine mammals,
such as absolute number of lymphocytes, eosinophils, and
monocytes [6], lymphocyte proliferation [10–13], phago-
cytosis [14], and nonspecific [15] and specific [16] im-
mune responses. The fact that the incidence of tumors is
also increasing in free-ranging dolphins suggests that
tumors can evade immune surveillance due to changes in
their immune parameters [17, 18].
In addition to environmental contaminants, the immuno-
suppressive effects of infectious diseases in dolphins have
also been reported in several studies. For example, dolphins
infected with lobomycosis, a mycotic skin disease, displayed
a suppressed immune system compared to dolphins
without a visible infection [19]. Dolphins with antibody
titers positive to bacterial infection, Chlamydiaceae,
showed changes in their innate and adaptive immuno-
logical parameters [20]. Dolphins with positive morbilli-
viral antibody titers had decreased T cell proliferation and
absolute number, suggestive of adverse changes in their
immune system [21]. Also, the deceased dolphins affected
by UMEs on the Atlantic coast of the U.S. and the Gulf of
Mexico had high prevalence of morbilliviral antigens,
lesions indicative of a morbillivirus infection, and second-
ary infections [22]. Of note, prior to these studies, it was
reported that dolphins affected by an UME in the Gulf of
Mexico had high levels of numerous immunosuppressive
chemicals and toxins in their liver and opportunistic infec-
tions [23].
Overall, these studies [6–16, 19–21, 24] shed light on
the immunosuppressive effects of contaminants or
microorganisms on dolphins’ immune system. In order
to better investigate a cause and effect relationship
between contaminants, immunosuppression, diseases
susceptibility and mortality leading to UMEs, it is essential
to characterize, monitor, and evaluate specific changes in
their immune cells. Flow cytometry is commonly used
method to monitor the immune status and disease
progression in humans and experimental laboratory
animals. However, this method has not been utilized in
dolphins due to lack of commercially available anti-
bodies specific to marine mammal immune cell surface
markers. We addressed this limitation by identifying
cross-reactive terrestrial-specific antibodies to pheno-
type the immune cells of dolphins under human care.
We then utilized these selected antibodies to monitor
the immune status of free-ranging dolphins by compar-
ing their immune cell subsets to those of dolphins
under human care.
Methods
Staining media and antibodies
Media containing PBS 1X, 2% heat-inactivated FCS and
2 mM EDTA was used to label cells with monoclonal
antibodies. Terrestrial monoclonal antibodies were
purchased from BD Bioscience (San Jose, CA) and
eBioscience (San Diego, CA). Antibodies tested that
were not cross-reactive; Human-specific: CD1a (HI149),
CD19 (SJ25C1), CD19 (1D3), CD62L (DREG56), HLA-DR
(G46-6 or L243) (eBioscience, CA), CD3 (UCHT1), CD3
(SP34-2), CD3e (SP34), CD3e (APA1/1), CD4 (M-T477),
CD4 (L200), CD8 (SK1), CD8 (HIT8a), CD8 (RPA-T8),
CD11b (ICRF44), CD15 (HI98), CD19 (HIB19), CD25
(MA251), CD45 (HI30), Ig Kappa Light Chain (polyclonal),
HLA-ABC (G46-2.6), and HLA-ABC (DX17) (BD Bio-
science, CA). Mouse-specific: CD4 (GK1.5), CD8a (53-
6.7), CD11b (M1/70), IA-IE (M5/114.15.2) (eBioscience,
CA), CD3 complex (17A2), CD3e (145-2C11), CD3e
(500A2), CD4 (RM4-5), CD45 (30-F11), and CD49b
(DX5) (BD Bioscience, CA). Rat-specific: CD80 (3H5)
(BD Bioscience, CA).
Antibodies tested that were cross-reactive but not
selected due to low detectability of corresponding markers;
Human-specific: CD11c (3.9) (eBioscience, CA). Mouse-spe-
cific: CD4 (H129.19), CD4 (RM4-4), CD8b (H35-17.2),
CD40 (3/23), CD80 (16-10A1), Ly-6G (1A8), H-2Kb (AF6-
88.5) (BD Bioscience), CD11c (N418), CD25 (PC61.5),
CD62L (MEL-14), B220 (RA3-6B2), and H2Ld-Db (28-14-
8) (eBioscience, CA). Rat-specific: CD3 (G4.18), CD4 (OX-
35), CD8a (OX-8), CD86 (24 F), and RT1A (OX-18) (BD
Bioscience, CA). Pig-specific: CD3e (BB23-8E6-8C8), CD4a
(74-12-4), and CD8a (76-2-11) (BD Bioscience, CA).
Antibodies tested that were cross-reactive and selected
due to high detectability of corresponding markers;
Human-specific: CD4 (RPA-T4), CD14 (61D3), CD56
(MEM188), HLA-DR (LN3) (eBioscience, CA), CD8
(G42-8), Ig Lambda Light Chain (polyclonal) (BD Bioscience,
CA), and HLA-ABC (W6/32) (DAKO). Mouse-specific:
CD40 (HM40-3) and Ly-6G and Ly-6C (RB6-8C) (BD
Bioscience, CA). Rat-specific: CD3 (1F4) and CD11b
(WT.5) (BD Bioscience).
Isotype controls for selected cross-reactive antibodies:
IgM kappa (G155-228), IgG2a kappa (G155-178), IgA
kappa (M18-254), IgM lambda (G235-1), IgG2b (A95-1)
(BD Bioscience, CA), and IgG1 kappa (P3.6.2.8.1), IgG2a
kappa (eBM2a), and IgG2b kappa (eBMG2b) (eBioscience,
CA). Isotype controls for clone HM40-3 and Ig Lambda
Light Chain were not available.
Source of dolphin blood samples
Atlantic bottlenose dolphin (Tursiops truncatus) blood
samples were obtained from nine captive dolphins under
human care at the Georgia Aquarium in Atlanta, Georgia
and 16 free-ranging dolphins in the estuarine areas of
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Charleston, South Carolina as part of the Dolphin Health
and Environmental Risk Assessment (HERA) Project.
Techniques and protocols related to the dolphin capture-
release practices of the HERA Project have been previously
described [25]. All samples were shipped overnight and
processed immediately. The Atlantic bottlenose dolphin
HERA Project was initiated as a multidisciplinary, inte-
grated, collaborative effort in 2003 to assess individual and
population health in two southeast coastal regions of the
USA: Charleston, SC and the Indian River Lagoon, FL
[26]. All methods used in the HERA Project for capture
and sample collection were approved under NMFs Scien-
tific Research Permit Nos. 9981678 and 14352-02 issued to
G. Bossart and Florida Atlantic University IACUC Protocol
Number A10-13. Samples from animals under human care
were obtained from the Georgia Aquarium facilities as part
of a routine preventative medicine program and were from
individual animals with normal clinical history and physical
examination.
Blood processing
Ficoll-Hypaque technique is commonly utilized in
humans to isolate PBMCs from peripheral blood to
study innate and adaptive immune cells and to use
monocytes to generate ex vivo dendritic cells (DCs).
We used this method to isolate peripheral blood mono-
nuclear cells (PBMCs) from dolphin peripheral blood
by centrifugation of blood samples with Ficoll-Paque
PLUS (Amersham Biosciences, NJ) in 50 ml Falcon-
tubes for 30 min at 900 × g at 20 °C. The viability of
PBMCs was quantitated by trypan blue staining and
was >95%. A fraction of the PBMCs were used for
labeling with corresponding monoclonal antibodies for
further analysis on flow cytometry. Remaining PBMCs
were frozen in freezing media containing 90% fetal calf
serum (FCS) and 10% dimethyl sulfoxide (DMSO) for
further analysis. There were no differences in expres-
sion levels of cellular markers observed whether fresh
or frozen PBMCs were used for phenotyping.
Immunophenotyping of PBMCs
Flow cytometry is commonly used to simultaneously
measure and analyze multiple characteristics of cells
within PBMCs, including size, granularity, and surface
marker expression. Prior to labelling, fresh or frozen
PBMCs were washed three times in a staining media
by resuspending and repeating the centrifugation steps
at 600 × g for 5 min. For labeling, cells pre-incubated
with mouse and rat serum were stained with the
fluorochrome-conjugated antibodies or matching iso-
type control antibodies for 30 min on ice in staining
media. To remove any unbound antibodies, the cells
were washed two times by centrifugation at 600 × g
for 5 min at 4 °C. Finally, the cells were transferred to
flow cytometry sample storage tubes containing stain-
ing media and 2% paraformaldehyde and kept at 4 °C
before acquisition on FACSCalibur flow cytometer using
Cell QuestPro acquisition software (BD Bioscience, San
Jose, CA). The data were analyzed using FlowJo software
(TreeStar, Ashland, OR).
Blood smear and cytopsin slide preparations
Blood smears were prepared using peripheral blood from dol-
phins under human care. Cytospin slides were prepared by
spinning isolated PBMCs from dolphins under human care
and free-ranging dolphins at 800 rpm for 5 min on a cytospin
centrifuge (Shandon Inc., Pittsburgh, PA). Blood smear and
cytospin slides were fixed and stained with Fisher Scientific
three step stain set. Slides were photographed on an Olympus
Provis AX microscope using Olympus cellSens software.
Statistical analysis
Values are presented as means ± SEM. To determine the
significance of data, statistical comparisons were performed
using a t-test assuming unequal variances. A p value <0.05
was statistically significant and shown as an asterisk (*).
Results
PBMCs isolated from peripheral blood display differences
between dolphins under human care and free-ranging
dolphins
Similar to humans and other species, dolphin peripheral
blood smears showed a heterogeneous population of
white bloods cells (WBCs): monocytes, lymphocytes,
and granulocytes, including neutrophils, basophils and
eosinophils (Fig. 1a). Using Ficoll-Hypaque technique,
we isolated on average 1.3 × 106 PBMCs/ml ranging
from 0.9 to 1.5 × 106 PBMCs/ml from peripheral blood
of dolphins under human care (Table 1). However, the
absolute number of PBMCs isolated from peripheral
blood of free-ranging dolphins was significantly higher
(three-fold) with an average of 3.1 × 106 PBMCs/ml
ranging from 1.3 to 9.0 × 106 PBMCs/ml (Table 1). In
addition, cytospin slides of isolated PBMCs from free-
ranging dolphins showed differences in cellular compos-
ition when compared to dolphins under human care,
specifically with a significant increase in granulocytes and
decrease in monocytes and lymphocytes (Fig. 1b).
Flow cytometry profile of PBMCs display differences
between dolphins under human care and free-ranging
dolphins
Similar to human PBMCs, the forward-scatter and side-
scatter (FSC/SSC) profile of total isolated PBMCs of
dolphins under human care showed two regions, re-
sembling the lymphocyte and monocyte fractions
(Fig. 2a). Interestingly, within the FSC/SSC profile of
free-ranging dolphins, we observed a third region
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Fig. 1 Morphology of peripheral white blood cells. a Whole peripheral blood smears of dolphins under human care. M-Monocyte, L-Lymphocyte
N-Neutrophil, B-Basophil, and E-Eosinophil. b Dolphins under human care (HC) and free-ranging dolphin (FR) isolated peripheral blood mononuclear
cells (PBMCs) spun on a cytospin centrifuge (Shandon Inc., Pittsburgh, PA) at 800 rpm for 5 mins. Blood smear and cytospin slides were fixed and
stained with Fisher Scientific three step stain set and photographed at 100X and 60X magnification, respectively
Table 1 Absolute number of peripheral blood mononuclear cells (PBMCs)
Dolphin # Blood Sample Volume (ml) PBMCs (x106) PBMCs/ml (x106) Monocytes (%) Lymphocytes (%) Granulocytes (%)
HC FR HC FR HC FR HC FR HC FR HC FR
1 (A) 16 12 20.6 25 1.3 2.1 17.5 20.8 64.5 41.4 2.74 22.1
2 (A) 14 20 21.8 93 1.5 4.7 24 12 54 58 4.7 9
3 (A) 15 20 18.6 50 1.5 2.5 13.7 14 31 62 15.6 3
4 (A) 16 15 16.8 20 1.4 1.3 12.5 15.3 66 54.9 2.86 13.4
5 (A) 12 20 17.4 74 1.2 3.7 19.4 11 61.5 64 1.78 5
6 (A) 14 20 12.9 86.5 1 4.3 12 6 72 64 1.35 15
7 (A) 11 20 15.6 75.6 0.9 3.8 12 11 67 54 3.02 11.7
8 (A) 15 20 19.1 37.6 1.3 1.9 14 16.6 66 45.5 1.92 27.3
9 (A) 13 20 16.3 92.4 1.2 4.6 28 7.5 48 47 2.27 24
10 (A) 18 30.3 1.7 17.8 49.3 6.9
11 (A) 15 47.4 3.2 7 60.5 16
12 (A) 20 27 1.4 13.5 68.6 6.7
13 (B) 20 32 1.6 7.7 17 56
14 (B) 20 25.4 1.3 4.8 16 58
15 (B) 20 180 9 1.8 9.5 74.5
16 (B) 20 42 2.1 17.6 20 64
Average 14 18.8 17.7 58.6 1.3 3.1 17 11.5 58.9 45.7 4.3 25.8
This table shows the Ficoll-Hypaque gradient isolated PBMC counts. Dolphins under human care dolphins (HC) from Georgia Aquarium (Atlanta, GA) and free-ranging dolphins
(FR) from the Dolphin Health and Environmental Risk Assessment (HERA) Project (Charleston, SC). The first column shows the number of dolphins sampled, dolphins under
human care (n= 9) and free-ranging (n=12 group A and n= 4 group B). The second column shows the total volume of blood collected from each dolphin. The third column
shows the total number of PBMCs isolated per blood sample. The fourth column shows the total number of PBMCs isolated per ml of blood. The fifth, sixth, and seventh
columns show the percentages of monocyte, lymphocyte, and granulocyte fractions within the isolated PBMCs, respectively. Also the table shows the average for each column
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ranging from low (<27%, group A free-ranging dol-
phins) to high (>56%, group B free-ranging dolphins)
percentage of cells with smaller size and similar
granularity but not identical density to granulocytes
(Fig. 2b and 2c).
Terrestrial-specific antibodies identify immune cell
subsets within the PBMCs of dolphins
There are currently no commercially available marine-
specific antibodies to distinguish cell types within PBMCs
of dolphins. In other species when specific monoclonal
antibodies are available lymphocyte fraction (region 1)
contains cells that express lymphocyte markers, including
T cells (CD3/4/8), B cells (CD19), and NK cells (CD56/
49b), while monocyte fractions (region 2) contains cells
that express monocyte (CD14/11b) and myeloid markers
(CD11b/40), all of them also differentially express major
histocompatibility (MHC) antigens (MHC class I/II). In
order to identify these immune cells within each region of
dolphins’ PBMCs, we took advantage of terrestrial anti-
bodies specific to human, mouse and rat. Amongst the 65
antibodies we tested, 32 showed cross-reactivity of which
11 with the highest cross-reactivity were selected for
further identification of these cells within the total PBMCs
(Table 2). We found that CD3/4/8, Ig Lambda (λ)/CD40/
11b, and CD56/11b monoclonal antibodies were able to
distinguish the cells within region 1 as T, B, and NK cells
(Fig. 3b) while CD14/11b/Ly-6G&C/40 and CD11b/
Ly-6G&C identified monocytes and myeloid cells re-
spectively within region 2 of dolphins under human
care (Fig. 3c). In addition, both regions contain cells
expressing antigen-presenting molecules, MHC class I
and II (Fig. 3b and 3c). These selected monoclonal
antibodies were also able to identify the same cell
subsets within regions 1 and 2 of normal free-ranging
dolphin PBMCs (Fig. 4b and 4c). Interestingly these
antibodies detected cells within region 3 of free-
ranging dolphins with characteristics of lymphocytes,
monocytes, myeloid cells, and granulocytes but lacked
expression of antigen-presenting molecules MHC
class I and II (Fig. 5b).
Frequency of immune cells within the PBMCs of dolphins
under human care and free-ranging dolphins expressing
specific surface markers
Our data shows that the differences in FSC/SSC profiles
observed between dolphins under human care and free-
ranging dolphins reflect increases or decreases in aver-
age percentage and absolute number of each immune
cell within the lymphocyte, monocyte, and granulocyte
regions. Indeed, the average percentage of cells in the
lymphocyte region expressing CD4, Ig λ, CD56 and
MHC class II surface markers was similar between dolphins
under human care and group A and B free-ranging dol-
phins (Fig. 6a). However the percentage of cells expressing
CD3 and CD8 were significantly increased while CD11b
was decreased in group A and CD40 was increased in
group B free-ranging dolphins when compared to dolphins
under human care (Fig. 6a). In addition, we observed a sig-
nificant increase in percentage of cells expressing MHC
class I in group A when compared to group B free-ranging
dolphins (Fig. 6a). Then we compared the absolute number
of dolphins under human care and free-ranging dolphins’
cells within the lymphocyte region expressing the indicated
markers. We found a significant increase in absolute
number of group A free-ranging dolphin cells expressing
CD3 and CD8 and a decrease in CD11b when compared to
dolphins under human care. Finally, group B free-ranging
dolphins showed a significant decrease in the absolute
number of cells expressing all markers and all markers
except CD8 when compared to group A free-ranging




















Fig. 2 Flow cytometry profile of total PBMCs. The forward-scatter and side-scatter (FSC/SSC) plots represent the total PBMCs profile and lymphocyte (R1),
monocyte (R2), and granulocyte (R3) regions. a Dolphins under human care lymphocyte, monocyte, and granulocyte regions; b group A free-ranging
dolphin lymphocyte, monocyte, and granulocyte regions; and c group B free-ranging dolphin lymphocyte, monocyte, and granulocyte regions
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(Fig. 7a). We also compared the differences in the per-
centage and absolute number of cells within the mono-
cyte region between dolphins under human care and
free-ranging dolphins. There was a significant decrease
in the percentage of group A free-ranging dolphin cells
expressing CD14, CD11b, and MHC class II compared to
dolphins under human care (Fig. 6b). There was also a sig-
nificant decrease in percentage of group B free-ranging
dolphin cells expressing MHC class I when compared to
group A free-ranging dolphins (Fig. 6b). When the abso-
lute number of cells within the monocyte region was
compared, we found a significant decrease in the absolute
number of group A free-ranging dolphin cells expressing
all markers, except Ly-6G&C when compared to dolphins
under human care (Fig. 7b). In addition, we found
group B free-ranging dolphins had a significant decrease
Table 2 Antibodies tested on dolphin Peripheral Blood Mononuclear Cells (PBMCs)
Antibody Clone Species Antibody Clone Species
Not cross-reactive Cross-reactive, not selected
CD1a HI149 Humana CD3 G4.18 Ratb
CD3 17A2 Mouseb CD3e BB23-8E6-8C8 Pigb
CD3 UCHT1 Humanb CD4 H129.19 Mouseb
CD3 SP34-2 Humanb CD4 RM4-4 Mouseb
CD3e SP34 Humanb CD4 OX-35 Ratb
CD3e APA1/1 Humanb CD4a 74-12-4 Pigb
CD3e 145-2C11 Mouseb CD8a OX-8 Ratb
CD3e 500A2 Mouseb CD8a 76-2-11 Pigb
CD4 M-T477 Humanb CD8b H35-17.2 Mouseb
CD4 L200 Humanb CD11c 3.9 Humana
CD4 RM4-5 Mouseb CD11c N418 Mousea
CD4 GK1.5 Mousea CD25 PC61.5 Mousea
CD8 SK1 Humanb CD40 23-Mar Mouseb
CD8 HIT8a Humanb CD62L MEL-14 Mousea
CD8 RPA-T8 Humanb CD80 16-10A1 Mouseb
CD8a 53-6.7 Mousea CD86 24F Ratb
CD11b M1/70 Mousea B220 RA3-6B2 Mousea
CD11b ICRF44 Humanb Ly-6G 1A8 Mouseb
CD15 HI98 Humanb MHC I (RT1A) OX-18 Ratb
CD19 HIB19 Humanb MHC I (H-2Kb) AF6-88.5 Mouseb
CD19 SJ25C1 Humana MHC I (H2Ld-Db) 28-14-8 Mousea
CD19 1D3 Mousea Cross-reactive, selected
CD25 MA251 Humanb CD3 1F4 Ratb
CD45 HI30 Humanb CD4 RPA-T4 Humana
CD45 30-F11 Mouseb CD8 G42-8 Humanb
CD49b DX5 Mouseb CD11b WT.5 Ratb
CD62L DREG56 Humana CD14 61D3 Humana
CD80 3H5 Ratb CD40 HM40-3 Mouseb
MHC I (HLA-ABC) G46-2.6 Humanb CD56 MEM188 Humana
MHC I (HLA-ABC) DX17 Humanb Ly-6G and Ly-6C RB6-8C5 Mouseb
MHC II (HLA-DR) G46-6 or L243 Humana MHC I (HLA-ABC) W6/32 Humanc
MHC II (IA-IE) M5/114.15.2 Mousea MHC II (HLA-DR) LN3 Humana
Ig κ Light Chain Polyclonal Humanb Ig λ Light Chain Polyclonal Humanb
Table lists the terrestrial-specific antibodies that were not cross-reactive, cross-reactive but not selected, or cross-reactive and selected. Letters denote the companies
where the antibodies were purchased. aeBioscience, bBD Bioscience, cDAKO
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in absolute number of cells expressing all markers when
compared to dolphins under human care and group A
free-ranging dolphins (Fig. 7b). Finally, we compared the
average percentage and absolute number of cells express-
ing each indicated marker within the granulocyte region
only seen in group A and B free-ranging dolphins. We
found that group B with a high increase in granulocytes
on FSC/SSC plots showed a greater percentage of cells for
almost all surface markers, although not significant
(Fig. 6c). Also, the absolute number of cells expressing
each indicated marker was significantly increased in group
B compared to group A free-ranging dolphins except
CD56, MHC class I, and MHC class II (Fig. 7c).
Discussion
In this study, we investigated dolphins under human
care that served as a healthy control model for dolphins
subject to routine health care in order to characterize
their immune cell subsets and compare them side by side to
those of free-ranging dolphins. Using a hemocytometer, we
found that Atlantic bottlenose dolphins under human care
have on average 6.5 × 106 white blood cells (WBCs)/ml of
blood (Table 3) which is lower than 10.95 × 106 WBCs/ml
reported in previous studies using an automatic cell counter
[27, 28]. This discrepancy is most likely due to differences in
counting methods. Indeed, using an automatic cell counter,
others [25, 29] and we (Table 3) found that free-ranging
Atlantic bottlenose dolphins have 11.0 × 106 WBCs/ml
of blood and 12.7 × 106 WBCs/ml, respectively. Within
the WBCs, studies showed that dolphins under human care
have 2.3% monocytes, 21.7% lymphocytes, 60.3% neutro-
phils, <1% basophils, and 14.5% eosinophils [27, 28, 30, 31],
while free-ranging dolphins have 2.9% monocytes, 21.1%
lymphocytes, 40.3% neutrophils, <1% basophils, and 35.9%
eosinophils [25, 29]. We observed that dolphins under
human care have 3.9% monocytes, 17.8% lymphocytes,
63.3% neutrophils, 1.2% basophils, and 12.1% eosinophils,
while free-ranging dolphins have 2.7% monocytes, 17%
lymphocytes, 39.5% neutrophils, 0.9% basophils, and
39.6% eosinophils within their WBCs (Table 3). The
decrease in lymphocytes and neutrophils and increase
in eosinophils that we observed in free-ranging com-
pared to dolphins under human care is consistent with




Fig. 3 Phenotype of cells within the PBMC gated regions. a Shows FSC/SSC profile of dolphins under human care PBMCs gated on lymphocyte
and monocyte regions. b Represents region 1 lymphocyte fraction with cells expressing the indicated surface markers: CD3/4/8 (T cells), Ig Lambda (λ)/
CD40/11b (B cells), CD11b/56 (NK cells), and MHC class I/MHC class II (antigen-presenting cells). c Represents region 2 monocyte fraction with cells
expressing the indicated surface markers: CD14/11b/Ly-6G&C/40 (monocytes), CD11b/Ly-6G&C (myeloid cells), and MHC class I/MHC class II
(antigen-presenting cells). Quadrants show the percentage of cells expressing the indicated markers. Upper plots represent cells stained with
isotype control antibodies
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[25, 27–31]. Of note, dolphins under human care and
free-ranging dolphins have a leukocyte differential simi-
lar to humans, except their eosinophil count which is
much higher than the 1–4% range seen in humans.
The FSC/SSC flow cytometery profile of free-ranging
dolphins’ PBMCs revealed that they can be divided into
group A and B based on low (<27%) and high (>56%)
percentage of granulocytes respectively (Fig. 2b and 2c).
In addition, group B free-ranging dolphins have the highest
average PBMC count of 3.5 × 106 per ml compared to
2.9 × 106 per ml for group A and 1.3 × 106 per ml for
dolphins under human care (Table 1). Furthermore, the
PBMCs of group B free-ranging dolphins have on average
a differential of 63% granulocytes, 8% monocytes, and 16%
lymphocytes while group A has 13% granulocytes, 13%
monocytes, and 56% lymphocytes, and dolphins under
human care have 17% monocytes and 59% lymphocytes
(Table 1). Therefore, our data revealed that group B
free-ranging dolphins have the lowest lymphocyte and
monocyte fractions of PBMCs compared to dolphins
under human care and group A free-ranging dolphins.
Consistent with our flow data, cytospin slides prepared
from PBMCs of group B free-ranging dolphins also
showed a decrease in lymphocytes and monocytes and
an increase in granulocytes compared to dolphins under
human care (Fig. 1b). Noteworthy, these observed changes
between dolphins under human care, group A, and
group B free-ranging dolphins were not unique to their
PBMCs since we found similar changes in total WBC
count and percentage of lymphocytes, monocytes, and
granulocytes within their WBCs. Indeed, group B com-
pared to group A free-ranging dolphins on average have
an increase in total WBC count 13.7 × 106 vs. 12.4 × 106
per ml and granulocytes 83.8% vs. 78.8% and a decrease in
lymphocytes 12.8% vs. 18.5% and monocytes 2.5% vs. 2.8%
(Table 3). Interestingly, within the granulocyte fraction
of total WBCs, group B free-ranging dolphins also have an
increase in neutrophils 51.8% vs. 35.4% and decrease in eo-
sinophils 31.3% vs. 42.4% compared to group A (Table 3).
Previous studies have labelled cells within various dolphin
tissues using human-specific antibodies [32, 33], which sug-
gest that human and dolphin cells share epitopes on their
A C
B
Fig. 4 Phenotype of cells within the PBMC gated regions. a Shows FSC/SSC profile of group A free-ranging dolphin PBMCs gated on lymphocyte
and monocyte regions. b Represents region 1 lymphocyte fraction with cells expressing the indicated surface markers: CD3/4/8 (T cells), Ig Lambda (λ)/
CD40/11b (B cells), CD11b/56 (NK cells), and MHC class I/MHC class II (antigen-presenting cells). c Represents region 2 monocyte fraction with
cells expressing the indicated surface markers: CD14/11b/Ly-6G&C/40 (monocytes), CD11b/Ly-6G&C (myeloid cells), and MHC class I/MHC class
II (antigen-presenting cells). Quadrants show the percentage of cells expressing the indicated markers. Upper plots represent cells stained with
isotype control antibodies
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cell surface markers. Our data further suggests that cell sur-
face markers on dolphin immune cells share epitopes with
humans and other species, since three of three pig, seven of
eight rat, 14 of 25 mouse and eight of 29 human specific
antibodies were cross-reactive. Interestingly, out of the 11
antibodies we selected to label dolphin immune cells, seven
human, two mouse, and two rat-specific antibodies had the
highest cross-reactivity. Therefore, our data demonstrated
that using pan surface markers commonly used in mouse
and human studies, we could detect dolphin immune cell
subsets, including CD3 T cells, CD56 NK cells, and CD14/
CD11b monocytes (Fig. 3 and 4). However, we were not
able to detect B cells in dolphins using the monoclonal
antibody specific to pan B cell marker CD19. Thus, we
instead utilized Ig lambda (λ) and CD40, as well as CD11b
known also to detect B cell subsets (Fig. 3b and 4b). De
Guise et al., [34], reported that 14.1% and 22.63% of
Atlantic bottlenose dolphins’ PBMCs expressed CD19
and CD21, respectively using non-commercially available
antibodies. However, these antibodies were not available to
us for comparison. Altogether, our selected antibodies were
able to detect dolphin immune cell subsets, even though
they may not have optimally represented the true percent-
age of immune cells and expression of their markers within
dolphin peripheral blood.
In humans and rodents, MHC class II expression is
restricted to antigen-presenting cells. We observed that
nearly all dolphin B and T lymphocytes and monocytes
express MHC class II (Fig. 3 and 4). Our finding is con-
sistent with previous studies that showed more than
90% of bottlenose dolphins’ [35] and beluga whales’
[36] peripheral blood cells within lymphocyte region
express MHC class II, which is also observed in ungulates
and carnivores such as swine [36], equine [37], canine
[38], and feline [39]. Although, MHC class I is displayed
on all human and mouse nucleated cells, we found that
A B
Fig. 5 Phenotype of cells within the PBMC gated regions. a Shows FSC/SSC of group B free-ranging dolphin PBMCs gated on granulocyte region.
b Represents region 3 granulocyte fraction with cells expressing the indicated surface markers: CD14/11b/Ly-6G&C/3/4/8/Ig Lambda (λ)/40/56/
MHC class I/MHC class II. Quadrants show the percentage of cells expressing these indicated markers. Upper plots represent cells stained with
isotype control antibodies
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only a small percentage of dolphin cells expressed MHC
class I (Fig. 3 and 4). Furthermore, our data revealed that
a similar percentage of cells expressed β2-microglobulin,
an invariant chain associated with MHC class I alpha
chain (data not shown). Using bovine-specific antibodies,
De Guise et al. [36], reported that majority of the cells
within the lymphocyte region of beluga whales expressed
MHC class I. Whether the discrepancies in MHC class I
expression in these studies was due to the antibodies used
for labelling or represents their true expression patterns
needs further investigation.
The WBC profile of dolphins contained two populations
of small and large cells with similar granularity within
granulocyte region (data not shown). During PBMC
isolation, Ficoll removed nearly all of the large but not
small granulocyte-like cells from blood samples of dolphins.
Interestingly however, the percentage of low density




Fig. 6 Percentage of cells within lymphocyte, monocyte, and granulocyte regions. a Represents the average percentage of cells expressing indicated
surface markers within the lymphocyte region of dolphins under human care (HC) and group A (FR-Group A) and B (FR-Group (b) free-ranging dolphins.
b Represents the average percentage of cells expressing indicated surface markers within the monocyte region of dolphins under human care (HC) and
group A (FR-Group A) and B (FR-Group B) free-ranging dolphins. c Represents the average percentage of cells expressing indicated surface markers within
the granulocyte region of group A (FR-Group A) and B (FR-Group B) free-ranging dolphins. Sample sizes are HC (n= 9), FR-Group A (n= 12), and FR-Group
B (n= 4). Values are presented as means ± SEM. An asterisk (*) denotes statistical significance
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free-ranging dolphins, which can also be seen on the cytos-
pin slides (Fig. 1b) was significantly higher than those
within PBMCs of dolphins under human care (Fig. 2). In
addition, these small granulocyte-like cells expressed all of
the markers, except MHC class I and II (Fig. 5b). Interest-
ingly, we observed that group B free-ranging dolphins with
the highest percentage of granulocytes in their PBMCs were
classified as diseased animals (Table 3). Whether the ob-
served changes in percentage, absolute number, and surface
markers of cells within PBMCs of dolphins under human
care and group A and B free-ranging dolphins was due to
increase in precursor cells, differences in maturational





Fig. 7 Absolute number of cells within lymphocyte, monocyte, and granulocyte regions. a Represents the average absolute number of cells
expressing indicated surface markers within the lymphocyte region of dolphins under human care (HC) and group A (FR-Group A) and B
(FR-Group B) free-ranging dolphins. b Represents the average absolute number of cells expressing indicated surface markers within the
monocyte region of dolphins under human care (HC) and group A (FR-Group A) and B (FR-Group B) free-ranging dolphins. c Represents
the average absolute number of cells expressing indicated surface markers within the granulocyte region of group A (FR-Group A) and B
(FR-Group B) free-ranging dolphins. Sample sizes are HC (n = 9), FR-Group A (n = 12), and FR-Group B (n = 4). Values are presented as
means ± SEM. An asterisk (*) denotes statistical significance
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Conclusions
Alterations in WBC count and distribution could provide
insight into the health status of dolphins, Indeed, It was
found that a bottlenose dolphin under human care infected
with Aspergillus fumigatus had a higher than normal WBC
count which decreased after treatment [40]. Another study
found that seals fed fish contaminated with immunosup-
pressive organochlorines had an increase in granulocytes
which the authors stated may indicate bacterial infections
[13]. However, alterations in WBC count offers little infor-
mation on specific changes imposed by environmental
factors on immune cell subsets and their function. In this
study, we have identified cross-reactive terrestrial-specific
antibodies that allowed us to characterize the immune cell
subsets of dolphins under human care and free-ranging
dolphins. Our findings opened the possibility of utilizing
flow cytometry for routine health assessment by monitoring
specific changes in immune cells of dolphins caused by
environmental contaminants or infectious agents with the
goal of understanding the pathogenesis of diseases.
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